Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated with Ozurdex Trial

PURPOSE: The Diabetic Macular Edema Treated with Ozurdex (DMEO) Trial measured aqueous pro-permeability factors (PPFs) in diabetic macular edema (DME) patients before and after injection of dexamethasone implant or vascular endothelial growth factor (VEGF)-neutralizing protein and correlated changes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Ophthalmol
Hauptverfasser: Campochiaro, Peter A., Hafiz, Gulnar, Mir, Tahreem A., Scott, Adrienne W., Zimmer-Galler, Ingrid, Shah, Syed M., Wenick, Adam S., Brady, Christopher J., Han, Ian, He, Lingmin, Channa, Roomasa, Poon, David, Meyerle, Catherine, Aronow, Mary Beth, Sodhi, Akrit, Handa, James T., Kherani, Saleema, Han, Yong, Sophie, Raafay, Wang, Guohua, Qian, Jiang
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482180/
https://ncbi.nlm.nih.gov/pubmed/27130369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2016.04.017
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge